E-LIB Suche - Ergebnisse für: Ostrosky-Zeichner, L.

1

Multicenter Registry of Patients Receiving Systemic Mold-Ac..:

Ostrosky-Zeichner, L. ; Nguyen, M. H. ; Bubalo, J....
Infectious Diseases and Therapy. , 2022

Link: https://doi.org/10.1007/..

2

Assessment of the Role of 1,3-β-d-Glucan Testing for the Di..:

Lamoth, F ; Akan, H ; Andes, D...
Clinical Infectious Diseases. 72 (2021) Supplement_2 - p. S102-S108 , 2021

Link: https://doi.org/10.1093/..

3

Clinical mycology today: A synopsis of the mycoses study gr..:

Pappas, Peter G ; Boulware, David R ; Kontoyiannis, Dimitrios P...
Medical Mycology. 58 (2020) 5 - p. 569-578 , 2020

Link: https://doi.org/10.1093/..

4

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Tria..:

Ostrosky-Zeichner, L. ; Shoham, S. ; Vazquez, J....
Clinical Infectious Diseases. 58 (2014) 9 - p. 1219-1226 , 2014

Link: https://doi.org/10.1093/..

5

Editorial Commentary: Candida glabrata and FKS Mutations: W..:

Ostrosky-Zeichner, L.
Clinical Infectious Diseases. 56 (2013) 12 - p. 1733-1734 , 2013

Link: https://doi.org/10.1093/..

6

(1,3)- -D-Glucan as a Prognostic Marker of Treatment Respon..:

Jaijakul, S. ; Vazquez, J. A. ; Swanson, R. N..
Clinical Infectious Diseases. 55 (2012) 4 - p. 521-526 , 2012

Link: https://doi.org/10.1093/..

7

Reply to Chow and Hurley:

Jaijakul, S. ; Ostrosky-Zeichner, L.
Clinical Infectious Diseases. 56 (2012) 3 - p. 466-467 , 2012

Link: https://doi.org/10.1093/..

8

Randomized Clinical Trials Design, Practice, and Reporting:

Ostrosky-Zeichner, L.
Clinical Infectious Diseases. 52 (2010) 2 - p. 281-282 , 2010

Link: https://doi.org/10.1093/..

9

Factors related to survival and treatment success in invasi..:

Horn, D. L. ; Ostrosky-Zeichner, L. ; Morris, M. I....
European Journal of Clinical Microbiology & Infectious Diseases. 29 (2009) 2 - p. 223-229 , 2009

Link: https://doi.org/10.1007/..

10

Risk-based fluconazole prophylaxis of Candida bloodstream i..:

Faiz, S. ; Neale, B. ; Rios, E....
European Journal of Clinical Microbiology & Infectious Diseases. 28 (2008) 6 - p. 689-692 , 2008

Link: https://doi.org/10.1007/..

11

Multicenter retrospective development and validation of a c..:

Ostrosky-Zeichner, L. ; Sable, C. ; Sobel, J....
European Journal of Clinical Microbiology & Infectious Diseases. 26 (2007) 4 - p. 271-276 , 2007

Link: https://doi.org/10.1007/..

12

Micafungin versus Caspofungin for Treatment of Candidemia a..:

Pappas, P. G. ; Rotstein, C. M. F. ; Betts, R. F....
Clinical Infectious Diseases. 45 (2007) 7 - p. 883-893 , 2007

Link: https://doi.org/10.1086/..

13

International, open-label, noncomparative, clinical trial o..:

Ostrosky-Zeichner, L. ; Kontoyiannis, D. ; Raffalli, J....
European Journal of Clinical Microbiology & Infectious Diseases. 25 (2006) 1 - p. 69-69 , 2006

Link: https://doi.org/10.1007/..

14

Reply to Upton et al:

Ostrosky-Zeichner, L. ; Finkelman, M. A.
Clinical Infectious Diseases. 42 (2006) 7 - p. 1056-1056 , 2006

Link: https://doi.org/10.1086/..

15

Infection Control as the Real Bug Patrol: "Gnats" in the Bu..:

Jean, W. ; Fisher, V. ; Grubb, L...
American Journal of Infection Control. 34 (2006) 5 - p. E67 , 2006

Link: https://doi.org/10.1016/..